ArticleFrontiers in pharmacology2024

Benserazide, a cystathionine beta-synthase (CBS) inhibitor, potentially enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and the HIF1-α/VEGF pathway.

Wei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.